Serum of patients with Guillain-Barre syndrome modulates mitogen-induced cytokine synthesis by normal peripheral blood mononuclear cells

N. Osna, I. Logina, N. Vilgert, E. Hagina, Y. Bersinsh, A. Zvirbliene, O. Shitova, M. Kirschfink, A. Sochnev

Research output: Contribution to journalArticle

Abstract

Molecular mechanisms in the pathogenesis of the Guillain-Barre Syndrome (GBS) are still obscure. There is some evidence that cytokines (especially interferon gamma: IFN-γ and tumour necrosis factor: TNF-α) are implicated in the disease development. In this study we investigated the possible impact of sera of GBS patient on the synthesis of IFN-γ and TNF-α by normal mononuclear cells. Peripheral blood mononuclear cells of healthy donors were exposed to mitogens in the presence or absence of GBS patients sera, and cytokines were measured in the supernatants. Cytokine production was modulated in a stage-dependent manner: at the progression phase, GBS sera up- regulated; whereas at the recovery phase patient's sera down-regulated both IFN-γ and TNF-α production. IFN-γ down-regulation was partly associated with the increased production of IL-10. Analysis of the C3 split product C3d revealed a strong activation of the complement system in GBS sera, thereby providing further evidence for a possible triggering effect of the complement on cytokine production and disease progression.

Original languageEnglish (US)
Pages (from-to)82-87
Number of pages6
JournalCentral-European Journal of Immunology
Volume24
Issue number2
StatePublished - Jan 1 1999

Fingerprint

Guillain-Barre Syndrome
Mitogens
Blood Cells
Cytokines
Serum
Complement Activation
Interleukin-10
Interferon-gamma
Disease Progression
Down-Regulation
Tumor Necrosis Factor-alpha
Tissue Donors

Keywords

  • C3d component
  • Complement
  • Guillain-Barre syndrome
  • Interferon gamma
  • Interleukin-10
  • Interleukin-12
  • Serum factor
  • Tumor necrosis factor alpha

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Serum of patients with Guillain-Barre syndrome modulates mitogen-induced cytokine synthesis by normal peripheral blood mononuclear cells. / Osna, N.; Logina, I.; Vilgert, N.; Hagina, E.; Bersinsh, Y.; Zvirbliene, A.; Shitova, O.; Kirschfink, M.; Sochnev, A.

In: Central-European Journal of Immunology, Vol. 24, No. 2, 01.01.1999, p. 82-87.

Research output: Contribution to journalArticle

Osna, N, Logina, I, Vilgert, N, Hagina, E, Bersinsh, Y, Zvirbliene, A, Shitova, O, Kirschfink, M & Sochnev, A 1999, 'Serum of patients with Guillain-Barre syndrome modulates mitogen-induced cytokine synthesis by normal peripheral blood mononuclear cells', Central-European Journal of Immunology, vol. 24, no. 2, pp. 82-87.
Osna, N. ; Logina, I. ; Vilgert, N. ; Hagina, E. ; Bersinsh, Y. ; Zvirbliene, A. ; Shitova, O. ; Kirschfink, M. ; Sochnev, A. / Serum of patients with Guillain-Barre syndrome modulates mitogen-induced cytokine synthesis by normal peripheral blood mononuclear cells. In: Central-European Journal of Immunology. 1999 ; Vol. 24, No. 2. pp. 82-87.
@article{20a87c7a873d49d189aa273416324871,
title = "Serum of patients with Guillain-Barre syndrome modulates mitogen-induced cytokine synthesis by normal peripheral blood mononuclear cells",
abstract = "Molecular mechanisms in the pathogenesis of the Guillain-Barre Syndrome (GBS) are still obscure. There is some evidence that cytokines (especially interferon gamma: IFN-γ and tumour necrosis factor: TNF-α) are implicated in the disease development. In this study we investigated the possible impact of sera of GBS patient on the synthesis of IFN-γ and TNF-α by normal mononuclear cells. Peripheral blood mononuclear cells of healthy donors were exposed to mitogens in the presence or absence of GBS patients sera, and cytokines were measured in the supernatants. Cytokine production was modulated in a stage-dependent manner: at the progression phase, GBS sera up- regulated; whereas at the recovery phase patient's sera down-regulated both IFN-γ and TNF-α production. IFN-γ down-regulation was partly associated with the increased production of IL-10. Analysis of the C3 split product C3d revealed a strong activation of the complement system in GBS sera, thereby providing further evidence for a possible triggering effect of the complement on cytokine production and disease progression.",
keywords = "C3d component, Complement, Guillain-Barre syndrome, Interferon gamma, Interleukin-10, Interleukin-12, Serum factor, Tumor necrosis factor alpha",
author = "N. Osna and I. Logina and N. Vilgert and E. Hagina and Y. Bersinsh and A. Zvirbliene and O. Shitova and M. Kirschfink and A. Sochnev",
year = "1999",
month = "1",
day = "1",
language = "English (US)",
volume = "24",
pages = "82--87",
journal = "Central-European Journal of Immunology",
issn = "1426-3912",
publisher = "Termedia Publishing House Ltd.",
number = "2",

}

TY - JOUR

T1 - Serum of patients with Guillain-Barre syndrome modulates mitogen-induced cytokine synthesis by normal peripheral blood mononuclear cells

AU - Osna, N.

AU - Logina, I.

AU - Vilgert, N.

AU - Hagina, E.

AU - Bersinsh, Y.

AU - Zvirbliene, A.

AU - Shitova, O.

AU - Kirschfink, M.

AU - Sochnev, A.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Molecular mechanisms in the pathogenesis of the Guillain-Barre Syndrome (GBS) are still obscure. There is some evidence that cytokines (especially interferon gamma: IFN-γ and tumour necrosis factor: TNF-α) are implicated in the disease development. In this study we investigated the possible impact of sera of GBS patient on the synthesis of IFN-γ and TNF-α by normal mononuclear cells. Peripheral blood mononuclear cells of healthy donors were exposed to mitogens in the presence or absence of GBS patients sera, and cytokines were measured in the supernatants. Cytokine production was modulated in a stage-dependent manner: at the progression phase, GBS sera up- regulated; whereas at the recovery phase patient's sera down-regulated both IFN-γ and TNF-α production. IFN-γ down-regulation was partly associated with the increased production of IL-10. Analysis of the C3 split product C3d revealed a strong activation of the complement system in GBS sera, thereby providing further evidence for a possible triggering effect of the complement on cytokine production and disease progression.

AB - Molecular mechanisms in the pathogenesis of the Guillain-Barre Syndrome (GBS) are still obscure. There is some evidence that cytokines (especially interferon gamma: IFN-γ and tumour necrosis factor: TNF-α) are implicated in the disease development. In this study we investigated the possible impact of sera of GBS patient on the synthesis of IFN-γ and TNF-α by normal mononuclear cells. Peripheral blood mononuclear cells of healthy donors were exposed to mitogens in the presence or absence of GBS patients sera, and cytokines were measured in the supernatants. Cytokine production was modulated in a stage-dependent manner: at the progression phase, GBS sera up- regulated; whereas at the recovery phase patient's sera down-regulated both IFN-γ and TNF-α production. IFN-γ down-regulation was partly associated with the increased production of IL-10. Analysis of the C3 split product C3d revealed a strong activation of the complement system in GBS sera, thereby providing further evidence for a possible triggering effect of the complement on cytokine production and disease progression.

KW - C3d component

KW - Complement

KW - Guillain-Barre syndrome

KW - Interferon gamma

KW - Interleukin-10

KW - Interleukin-12

KW - Serum factor

KW - Tumor necrosis factor alpha

UR - http://www.scopus.com/inward/record.url?scp=0033430338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033430338&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033430338

VL - 24

SP - 82

EP - 87

JO - Central-European Journal of Immunology

JF - Central-European Journal of Immunology

SN - 1426-3912

IS - 2

ER -